Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
5/13/2024 | $12.50 → $13.25 | Sell → Neutral | B. Riley Securities |
1/8/2024 | $13.00 | Neutral → Sell | B. Riley Securities |
8/14/2023 | $15.00 | Outperform → Perform | Oppenheimer |
6/16/2023 | $14.00 | Neutral | B. Riley Securities |
3/2/2023 | Outperform → Mkt Perform | Raymond James | |
10/5/2022 | $11.00 | Neutral | Janney |
11/1/2021 | $15.00 | Perform → Outperform | Oppenheimer |
11/1/2021 | $15.00 → $15.50 | Outperform | Raymond James |
Stellus Capital Management, LLC ("Stellus") today announced the hiring of Zachary Roberson as Vice President, Director of High-Net-Worth Investor Relations. Mr. Roberson's primary responsibilities will entail servicing existing LP relationships, fundraising, and executing across all channels of Private Wealth, including Wirehouses, Independent Broker-Dealers, RIAs, Family Offices, Fintech Platforms, and Custodians. "We are pleased to welcome Zack to Stellus," said Ryan Hughes, Managing Director, Head of Investor Relations at Stellus. "With his strong experience in raising capital and client coverage capacities across both traditional and alternative investments, Zack is an excellent add
Shares of Indivior PLC (NASDAQ:INDV) rose sharply in today's pre-market trading after the company posted better-than-expected second-quarter results and announced an accelerated $100 million share repurchase program. Indivior reported quarterly earnings of 44 cents per share which beat the analyst consensus estimate of 14 cents per share. The company reported quarterly sales of $299.00 million which beat the analyst consensus estimate of $296.05 million. Indivior shares jumped 14.5% to $12.46 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Psyence Biomedical Ltd. (NASDAQ:PBM) rose 157.4% to $1.00 in pre-market trading after the company
B. Riley Securities analyst Bryce Rowe upgrades Stellus Cap Investment (NYSE:SCM) from Sell to Neutral and raises the price target from $12.5 to $13.25.
Stellus Cap Investment (NYSE:SCM) reported quarterly earnings of $0.44 per share which missed the analyst consensus estimate of $0.45 by 2.22 percent. This is a 2.22 percent decrease over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $25.996 million which missed the analyst consensus estimate of $26.643 million by 2.43 percent. This is a 7.98 percent increase over sales of $24.075 million the same period last year.
HOUSTON, Oct. 30, 2024 /PRNewswire/ -- Stellus Capital Investment Corporation (NYSE:SCM) will release its financial results for the third quarter ended September 30, 2024 on Thursday, November 7, 2024, after the close of the stock market. Stellus Capital Investment Corporation will host a conference call to discuss these results on Friday, November 8, 2024 at 11:00 AM, Central Time. The conference call will be led by Robert T. Ladd, Chief Executive Officer, and W. Todd Huskinson, Chief Financial Officer, Chief Compliance Officer, Treasurer, and Secretary. Conference Call Detai
HOUSTON, Oct. 10, 2024 /PRNewswire/ -- Stellus Capital Investment Corporation (the "Company") (NYSE:SCM) announced that its Board of Directors has declared a monthly dividend of $0.1333 for each of October, November, and December, totaling $0.40 per share in the aggregate for the fourth quarter of 2024. The regular dividend of $0.40 per share will be paid to shareholders of record in November and December 2024, and January 2025. Summary of Fourth Quarter 2024 Regular Monthly Dividends Declared Ex-Dividend Date Record Date Payment Date Amount per Share 10/10/2024 10/31/2024 10/
HOUSTON, Aug. 7, 2024 /PRNewswire/ -- Stellus Capital Investment Corporation (NYSE:SCM) ("Stellus" or the "Company") today announced financial results for its second fiscal quarter ended June 30, 2024. Robert T. Ladd, Chief Executive Officer of Stellus, stated, "I am pleased to report solid operating results for the quarter ended June 30, 2024, in which U.S. GAAP net investment income of $0.48 per share and core net investment income of $0.50 per share covered the regular dividend declared of $0.40 per share. Our loan portfolio is yielding 11.7%, as of June 30, 2024. We have c
4 - Stellus Capital Investment Corp (0001551901) (Issuer)
4 - Stellus Capital Investment Corp (0001551901) (Issuer)
4 - Stellus Capital Investment Corp (0001551901) (Issuer)
8-K - Stellus Capital Investment Corp (0001551901) (Filer)
10-Q - Stellus Capital Investment Corp (0001551901) (Filer)
8-K - Stellus Capital Investment Corp (0001551901) (Filer)
HOUSTON, Oct. 30, 2024 /PRNewswire/ -- Stellus Capital Investment Corporation (NYSE:SCM) will release its financial results for the third quarter ended September 30, 2024 on Thursday, November 7, 2024, after the close of the stock market. Stellus Capital Investment Corporation will host a conference call to discuss these results on Friday, November 8, 2024 at 11:00 AM, Central Time. The conference call will be led by Robert T. Ladd, Chief Executive Officer, and W. Todd Huskinson, Chief Financial Officer, Chief Compliance Officer, Treasurer, and Secretary. Conference Call Detai
HOUSTON, Oct. 10, 2024 /PRNewswire/ -- Stellus Capital Investment Corporation (the "Company") (NYSE:SCM) announced that its Board of Directors has declared a monthly dividend of $0.1333 for each of October, November, and December, totaling $0.40 per share in the aggregate for the fourth quarter of 2024. The regular dividend of $0.40 per share will be paid to shareholders of record in November and December 2024, and January 2025. Summary of Fourth Quarter 2024 Regular Monthly Dividends Declared Ex-Dividend Date Record Date Payment Date Amount per Share 10/10/2024 10/31/2024 10/
HOUSTON, Aug. 7, 2024 /PRNewswire/ -- Stellus Capital Investment Corporation (NYSE:SCM) ("Stellus" or the "Company") today announced financial results for its second fiscal quarter ended June 30, 2024. Robert T. Ladd, Chief Executive Officer of Stellus, stated, "I am pleased to report solid operating results for the quarter ended June 30, 2024, in which U.S. GAAP net investment income of $0.48 per share and core net investment income of $0.50 per share covered the regular dividend declared of $0.40 per share. Our loan portfolio is yielding 11.7%, as of June 30, 2024. We have c
B. Riley Securities upgraded Stellus Capital from Sell to Neutral and set a new price target of $13.25 from $12.50 previously
B. Riley Securities downgraded Stellus Capital from Neutral to Sell and set a new price target of $13.00
Oppenheimer downgraded Stellus Capital from Outperform to Perform and set a new price target of $15.00